Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Steward would become largest for-profit hospital operator after IASIS merger

Boston-based Steward Health Care System would become the largest for-profit hospital operator in the U.S. if it wins regulatory approval for a $2 billion merger with Franklin, Tennessee-based IASIS Healthcare. 

Thumbnail

HFMA ANI 2017 preview: ‘Healthcare finance has always been about change’

Policy uncertainty, changing reimbursement models and price transparency are just some of the topics expected to be discussed at the Healthcare Financial Management Association’s upcoming Annual National Institute, which runs from June 25 to 28 at the Orange County Convention Center in Orlando, Florida. 

Email provides new tool to help smokers quit

Smoking cessation can be a daunting task for many smokers—but help could be found in your email inbox. An American Cancer Society study, published in Tobacco Control, found personalized and frequent emails were as effective in helping patients quit smoking as many leading medications. 

Athenahealth sale ‘possible’ with activist investor taking 9.2% stake

Activist hedge fund manager Paul Singer of Elliott Management disclosed its 9.2 percent stake in Watertown, Massachusetts-based Athenahealth, sending the company’s stock price soaring.

Rural hospital turns to GoFundMe to stay open

The only hospital in Polk County, Tennessee, has laid off 15 nurses, halted all inpatient care and started a crowdfunding campaign in hopes of raising $100,000.

Trump budget would limit NIH grant recipients' spending on admin, IT

A cap could be placed on what “indirect” medical research costs can be covered by National Institutes of Health (NIH) grants, which researchers warn could “disembowel” their institutions.

Safety testing could prevent adverse drug reactions, reduce costs

Testing new medications can be risky, especially without an effective monitoring program. A study, published in Medical Care, evaluated the impact drug safety monitoring could have on detecting unsafe medications, improving patient care and controlling medical costs.

UnitedHealth hit with another DOJ lawsuit over Medicare Advantage fraud

The U.S. Department of Justice (DOJ) is again involved in a lawsuit alleging UnitedHealth Group (UHG) received Medicare Advantage payments to which it wasn’t entitled.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.